内部人交易雷达

美国 · SEC Form 4 · 快照日期： 2026-10-18 · 构建时间： 2026-10-18 · English

← 美国市场 · 覆盖记录

美国 · SEC FORM 4

TENAX THERAPEUTICS, INC.

TENX · Nasdaq · CIK 0000034956 · Healthcare · Biotechnology

内部人信号

78.6 / 100

4 位买方 · 11 条买入交易行 · $4.9M 买入总额

为什么有这个信号？

买方广度较强
买入规模较强
角色中等
近期性中等
确信度较强
评分构成

每条进度条表示其对当前分数的贡献；权重和公式保持不变。

Cluster+28.0 / 35
买入规模+21.7 / 25
角色+13.0 / 20
近期性+5.9 / 10
确信度+10.0 / 10

哪些因素限制了当前分数？

  • ⚠ 角色得分低 · 买入者中职位最高的是：CEO（CEO、董事长和持股 10% 以上的股东得分最低）
  • ✓ Cluster breadth is broad · 4+ insiders

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。

AprMayJunJulAugSepOct
ADAR1 Capital Management, LLC; Schneeberger DanielTenPercentOwner
●●●●●●●
Giordano Christopher ThomasCEO
○●●
STAAB THOMAS R IIChief Financial Officer
○●
Doogan DeclanDirector
●
● 买入▼ 卖出○ 其他

—

买方广度与集中度

合资格买方4
买入集中度97%最大买方： ADAR1 Capital Management, LLC; Schneeberger Daniel · $4.8M
聚集买入 · 15天4 insiders峰值活动： 2026-09-01–2026-09-16

Roles in the peak window: CEO, Chief Financial Officer, Director, TenPercentOwner. Concentration uses priced qualifying P lines only and does not change the saved score.

信号历史

78.6 / 100

最新留档分数

↓ -0.2 pts相对上一个留档快照
  1. 79.1
  2. 79.0
  3. 79.0
  4. 78.8
  5. 78.6

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

近期 Form 4 活动

26买入
0卖出
3其他 Form 4 交易行
14SEC 申报 · 365天
买入11 qualifying P line(s) · 180 days
卖出0 sale line(s) · 仅供背景
其他3 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not detected in parsed evidence

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

市场背景补充近期价格表现与风险信息，不影响内部人信号。

价格表现

1M
-4.1%
3M
-88.3%
6M
-87.0%
12M
-76.1%

波动率与流动性

波动率
96.2%
Beta
—
平均每日成交额
USD 10.4M

估值

市值
USD 70.0M
P/E
—

基本面

利润率
—
ROE
-54.2%
细分行业
Biotechnology

市场数据

价格数据截至：2026-10-11 · 价格来源：OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件：市值, ROE · 财年截止日：2025-12-31 · 市值 = 申报文件封面所列的已发行股数 × 最新收盘价。股数日期：2026-07-28 · Status: PASS

空头余额

空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。

空头股数
7,182,126
上期报告
5,503,842
日均成交量
3,061,372
回补天数
2.4

FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting owner类型证券股数平均价格估算金额来源
2026-09-16Doogan Declan买入 (P)Common Stock53,000USD 1.92USD 101,760SEC 申报 ↗
2026-09-15Giordano Christopher Thomas买入 (P)Common Stock4,850USD 1.82USD 8,827SEC 申报 ↗
2026-09-11STAAB THOMAS R II买入 (P)Common Stock5,675USD 1.94USD 11,010SEC 申报 ↗
2026-09-11Giordano Christopher Thomas买入 (P)Common Stock6,000USD 1.88USD 11,280SEC 申报 ↗
2026-09-03ADAR1 Capital Management, LLC; Schneeberger Daniel买入 (P)Common Stock900,000USD 1.78USD 1,602,000SEC 申报 ↗
2026-09-02ADAR1 Capital Management, LLC; Schneeberger Daniel买入 (P)Common Stock187,704USD 1.80USD 337,867SEC 申报 ↗
2026-09-01ADAR1 Capital Management, LLC; Schneeberger Daniel买入 (P)Common Stock179,058USD 1.80USD 322,304SEC 申报 ↗
2026-08-31ADAR1 Capital Management, LLC; Schneeberger Daniel买入 (P)Common Stock403,571USD 1.79USD 722,392SEC 申报 ↗
2026-08-24ADAR1 Capital Management, LLC; Schneeberger Daniel买入 (P)Common Stock107,374USD 1.75USD 187,904SEC 申报 ↗
2026-08-21ADAR1 Capital Management, LLC; Schneeberger Daniel买入 (P)Common Stock716,369USD 1.77USD 1,267,973SEC 申报 ↗
2026-08-20ADAR1 Capital Management, LLC; Schneeberger Daniel买入 (P)Common Stock202,124USD 1.78USD 359,781SEC 申报 ↗
2025-12-09Rich Stuart买入 (P)Common Stock2,500USD 10.22USD 25,550SEC 申报 ↗
2025-12-08Rich Stuart买入 (P)Common Stock2,500USD 10.10USD 25,250SEC 申报 ↗
2025-12-04Rich Stuart买入 (P)Common Stock2,500USD 9.20USD 23,000SEC 申报 ↗
2025-12-03Rich Stuart买入 (P)Common Stock1,500USD 9.08USD 13,620SEC 申报 ↗

Form 4 申报证据

29 transaction lines in the latest 365-day window; 70 in local history.

日期申报人类型证券股数平均价格估算金额来源
2026-09-16Doogan Declan买入 (P)Common Stock53,000USD 1.92USD 101,760SEC 申报 ↗
2026-09-15Giordano Christopher Thomas买入 (P)Common Stock4,850USD 1.82USD 8,827SEC 申报 ↗
2026-09-11STAAB THOMAS R II买入 (P)Common Stock5,675USD 1.94USD 11,010SEC 申报 ↗
展开近期 Form 4 证据 (26 grouped rows)
日期申报人类型证券股数平均价格估算金额来源
2026-09-16Doogan Declan买入 (P)Common Stock53,000USD 1.92USD 101,760SEC 申报 ↗
2026-09-15Giordano Christopher Thomas买入 (P)Common Stock4,850USD 1.82USD 8,827SEC 申报 ↗
2026-09-11STAAB THOMAS R II买入 (P)Common Stock5,675USD 1.94USD 11,010SEC 申报 ↗
2026-09-11Giordano Christopher Thomas买入 (P)Common Stock6,000USD 1.88USD 11,280SEC 申报 ↗
2026-09-03ADAR1 Capital Management, LLC; Schneeberger Daniel买入 (P)Common Stock900,000USD 1.78USD 1,602,000SEC 申报 ↗
2026-09-02ADAR1 Capital Management, LLC; Schneeberger Daniel买入 (P)Common Stock187,704USD 1.80USD 337,867SEC 申报 ↗
2026-09-01ADAR1 Capital Management, LLC; Schneeberger Daniel买入 (P)Common Stock179,058USD 1.80USD 322,304SEC 申报 ↗
2026-08-31ADAR1 Capital Management, LLC; Schneeberger Daniel买入 (P)Common Stock403,571USD 1.79USD 722,392SEC 申报 ↗
2026-08-24ADAR1 Capital Management, LLC; Schneeberger Daniel买入 (P)Common Stock107,374USD 1.75USD 187,904SEC 申报 ↗
2026-08-21ADAR1 Capital Management, LLC; Schneeberger Daniel买入 (P)Common Stock716,369USD 1.77USD 1,267,973SEC 申报 ↗
2026-08-20ADAR1 Capital Management, LLC; Schneeberger Daniel买入 (P)Common Stock202,124USD 1.78USD 359,781SEC 申报 ↗
2026-07-13Giordano Christopher Thomas期权行权／转换 (M)Common Stock8,719USD 5.88USD 51,267SEC 申报 ↗
2026-05-11STAAB THOMAS R II奖励／授予 (A)Common Stock10,000USD 0.00USD 0SEC 申报 ↗
2025-12-09Rich Stuart买入 (P)Common Stock2,500USD 10.22USD 25,550SEC 申报 ↗
2025-12-08Rich Stuart买入 (P)Common Stock2,500USD 10.10USD 25,250SEC 申报 ↗
2025-12-04Rich Stuart买入 (P)Common Stock2,500USD 9.20USD 23,000SEC 申报 ↗
2025-12-03Rich Stuart买入 (P)Common Stock1,500USD 9.08USD 13,620SEC 申报 ↗
2025-12-02Rich Stuart买入 (P)Common Stock1,000USD 9.01USD 9,010SEC 申报 ↗
2025-11-20Giordano Christopher Thomas买入 (P)Common Stock538USD 7.59USD 4,083SEC 申报 ↗
2025-11-19Giordano Christopher Thomas买入 (P)Common Stock455USD 7.51USD 3,417SEC 申报 ↗
2025-11-18Giordano Christopher Thomas买入 (P)Common Stock1,612USD 7.75USD 12,493SEC 申报 ↗
2025-11-18Almenoff June Sherie买入 (P)Common Stock1,900USD 7.52USD 14,288SEC 申报 ↗
2025-11-18Almenoff June Sherie买入 (P)Common Stock1,900USD 7.52USD 14,288SEC 申报 ↗
2025-11-17Almenoff June Sherie买入 (P)Common Stock93USD 7.15USD 665SEC 申报 ↗
2025-11-17MCGAULEY THOMAS买入 (P)Common Stock8,000USD 7.27USD 58,180SEC 申报 ↗
2025-11-17Almenoff June Sherie买入 (P)Common Stock93USD 7.15USD 665SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期2026-10-18
排名版本US-v1.2
数据质量PASS ELIGIBLE · —
股票代码TENX
CIK0000034956
行业Healthcare
细分行业Biotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
交易所Nasdaq

数据覆盖

本地 Form 4 历史70 transaction lines from 2020-05-18 to 2026-09-16
55 P purchase lines · 0 S sale lines · 15 other lines
SEC 公司申报打开 SEC 申报 ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.